Express Scripts to calculate 'blended' drug prices

Express Scripts Holding Co. (NASDAQ:ESRX) CMO Steve Miller said the company will create a "blended price" for drugs as part of its new indication-based pricing scheme. At an HHS forum on prescription drug pricing, Miller said Express Scripts will calculate the blended price based on varying prices for different indications, allowing it to avoid running afoul of a legal requirement that manufacturers offer Medicaid drugs at a best price that could be tied to the drug's worst-performing indication. ...